Jiangsu Weihe Biotechnology Attends the 11th National Academic Annual Conference on Blood Transfusion Medicine

The 11th National Academic Annual Conference on Blood Transfusion Medicine, sponsored by the Chinese Medical Association and the Blood Transfusion Branch of the Chinese Medical Association, and co organized by the Clinical Transfusion Branch of the Chinese Medical Association, the Sino Japanese Friendship Hospital of Jilin University, the Jilin Cancer Hospital, and the First Hospital of Jilin University, is scheduled to be held in Changchun, Jilin Province from August 8th to 11th, 2018. The theme of the conference is: Healthy China, Starting a New Journey of Secondary Discipline in Blood Transfusion Medicine in the New Era.
Jiangsu Weihe Biotechnology successfully participated in this conference. During the conference, the company showcased the latest products in the fields of precision drug guidance, blood immunity, and transplant immunity, consolidating existing cooperative relationships, exploring a large number of potential customers, and laying a solid foundation for expanding the market.
During the two-day exhibition, the Weihe Biotechnology booth attracted countless exhibitors to stop, and the staff always communicated with the exhibitors with full enthusiasm and patience, introducing the characteristics and advantages of the products in detail to the audience. Many visitors expressed great interest and hoped to deepen cooperation through this opportunity.
Weihe Biotechnology is committed to improving the core competitiveness of China's nucleic acid molecule field with excellent products, advanced technological advantages, and a scientific and rigorous work attitude.
     
    

Previous article： The construction of the factory building has been basically completed

Next article： The 9th China Taizhou International Medical Expo has come to a successful conclusion